Magazine Article | July 5, 2018

Dermatology — A Growth Opportunity For Those Willing To Risk Colossal Failure

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Ever experience a Phase 3 failure?

How about one resulting in a stock price drop of 80 percent?

What about a Phase 3 failure where your company’s stock price plummets 85 percent and you agree to teach about the experience (for roughly 10 years) to a class of MBA students (while continuing to work full time in industry) at one of the most prestigious business schools in the country?